Mangalam Drugs & Organics Limited (MANGALAM.BO)
INR 117.55
(-0.34%)
INR 117.55
(-0.34%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 3.68 Billion | 3.65 Billion | 4.47 Billion | 3.79 Billion | 2.82 Billion | 2.23 Billion |
| Cost of Revenue | 2.98 Billion | 2.95 Billion | 3.48 Billion | 2.82 Billion | 2.19 Billion | 1.76 Billion |
| Gross Profit | 703.6 Million | 701.5 Million | 987.42 Million | 976.68 Million | 630.91 Million | 475.36 Million |
| Operating Expenses | 676.14 Million | 555.63 Million | 599.78 Million | 532.22 Million | 475.62 Million | 448.9 Million |
| Selling, General and Administrative Expenses | - | 154.41 Million | 150.64 Million | 134.25 Million | 121.11 Million | 98.76 Million |
| Research and Development Expenses | - | - | - | - | - | 37.15 Million |
| Other Expenses | 676.14 Million | 835 Thousand | 344 Thousand | 333 Thousand | 2.77 Million | 1.48 Million |
| Cost and Expenses | 3.65 Billion | 3.51 Billion | 4.08 Billion | 3.35 Billion | 2.66 Billion | 2.21 Billion |
| Operating Income | 27.45 Million | 150.96 Million | 355.66 Million | 443.24 Million | 163.22 Million | 27.85 Million |
| Interest Expense | 139.17 Million | 89.2 Million | 72.02 Million | 63.2 Million | 64.95 Million | 66.15 Million |
| Income Tax Expense | -20.01 Million | 9.43 Million | 80.75 Million | 115.48 Million | -20 Million | 22.93 Million |
| Earnings before Tax | -110.73 Million | 22.13 Million | 277.32 Million | 395.19 Million | 62.52 Million | -57.37 Million |
| Net Income | -90.71 Million | 12.7 Million | 196.57 Million | 279.7 Million | 82.52 Million | -80.3 Million |
| Earnings Per Share Basic | -5.73 | 0.80 | 12.42 | 17.67 | 5.21 | -5.07 |
| Earnings Per Share Diluted | -5.73 | 0.80 | 12.42 | 17.67 | 5.21 | -5.07 |
| Weighted Average Shares Outstanding | 15.83 Million | 15.82 Million | 15.82 Million | 15.82 Million | 15.82 Million | 15.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.83 Million | 15.82 Million | 15.82 Million | 15.82 Million | 15.82 Million | 15.82 Million |
| Gross Margin | 0.19 | 0.19 | 0.22 | 0.26 | 0.22 | 0.21 |
| EBIT Margin | 0.05 | 0.06 | 0.10 | 0.14 | 0.07 | 0.04 |
| Profit Margin | -0.02 | 0.00 | 0.04 | 0.07 | 0.03 | -0.04 |
| EBITDA | 174.94 Million | 109.88 Million | 491.44 Million | 579.77 Million | 248.74 Million | 99.97 Million |
| Earnings Before Tax Margin | 0.01 | 0.04 | 0.08 | 0.12 | 0.06 | 0.01 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 765.36 Million | 3.68 Billion | 1.02 Billion | 973.35 Million | 813.66 Million | 870.03 Million |
| Cost of Revenue | 538.55 Million | 2.98 Billion | 736.28 Million | 818.64 Million | 507.18 Million | 658.71 Million |
| Gross Profit | 226.8 Million | 703.6 Million | 286.07 Million | 154.71 Million | 306.48 Million | 211.31 Million |
| Operating Expenses | 183.67 Million | 676.14 Million | 207.75 Million | 121.21 Million | 322.11 Million | 280.24 Million |
| Selling, General and Administrative Expenses | 183.67 Million | - | 207.75 Million | 121.21 Million | 185.53 Million | 161.85 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 202 Thousand | 980 Thousand | - | 19 Thousand | 499 Thousand | 196 Thousand |
| Cost and Expenses | 722.23 Million | 3.65 Billion | 944.03 Million | 939.86 Million | 829.29 Million | 938.96 Million |
| Operating Income | 43.12 Million | 27.45 Million | 78.31 Million | 33.49 Million | -15.63 Million | -68.93 Million |
| Interest Expense | 37.48 Million | 139.17 Million | 39.5 Million | 33.09 Million | 32.44 Million | 34.11 Million |
| Income Tax Expense | -21 Million | -20.01 Million | 3.98 Million | -4.56 Million | -11.93 Million | -7.5 Million |
| Earnings before Tax | 5.84 Million | -110.73 Million | 39.28 Million | 418 Thousand | -47.58 Million | -102.85 Million |
| Net Income | 26.84 Million | -90.71 Million | 35.3 Million | 4.97 Million | -35.64 Million | -95.35 Million |
| Earnings Per Share Basic | 1.70 | - | 223.00 | 0.31 | -2.25 | -6.02 |
| Earnings Per Share Diluted | 1.70 | - | 2.23 | 0.31 | -2.25 | -6.02 |
| Weighted Average Shares Outstanding | 15.82 Million | 15.83 Million | 15.82 Million | 15.82 Million | 15.82 Million | 15.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.82 Million | 15.83 Million | 15.82 Million | 15.82 Million | 15.82 Million | 15.82 Million |
| Gross Margin | 0.30 | 0.19 | 0.28 | 0.16 | 0.38 | 0.24 |
| EBIT Margin | 0.11 | - | 0.11 | 0.07 | 0.03 | -0.04 |
| Profit Margin | 0.04 | -0.02 | 0.03 | 0.01 | -0.04 | -0.11 |
| EBITDA | 81.9 Million | - | 116.96 Million | 69.77 Million | 22.26 Million | -34.54 Million |
| Earnings Before Tax Margin | 0.06 | 0.01 | 0.08 | 0.03 | -0.02 | -0.08 |
4255
0L7G
300076
LKE
1793
004890